 |
 |
Novartis AG will cut stake in Indian arm to meet SEBI norms
28 March 2013
|
|
|
|
Novartis expects ‘negative’ SC verdict in Glivet patent case
28 March 2013
|
|
|
Chairman steps down even as Novartis posts profit rise
24 January 2013
|
| | |
|
|
Cipla appoints Novartis' Subhanu Saxena as new CEO
22 November 2012
|
|
|
Novartis receives FDA approval to make first cell-culture vaccine in US for seasonal influenza
21 November 2012
|
|
|
Supreme Court asks Novartis to cut price of Glivec
13 September 2012
|
|
|
Glivec is `special’, Novartis argues in Supreme Court
11 September 2012
|
|
|
Novartis restructures US operations, to cut 1,960 jobs
14 January 2012
|
|
|
Mylan launches first generic version of Novartis' dementia drug Exelon
27 October 2011
|
|
|
Novartis to eliminate 2,000 jobs, close two sites in Europe
25 October 2011
|
|
|
European regulator launches antitrust probe against Novartis and J&J
24 October 2011
|
|
|
Novartis to file breast cancer combination drug Afinitor
05 July 2011
|
|
|
GW Pharma, Novartis sign deal to market cannabis derivative
12 April 2011
|
|
|
Novartis to acquire cancer diagnostics company Genoptix for $470 million
25 January 2011
|
|
|
Novartis plans $500 million investment in Russia
21 December 2010
|
|
|
ImmunoGen to collaborate with Novartis on novel cancer treatment
12 October 2010
|
|
|
Novartis aqnnounces novel antimalarial drug
06 September 2010
|
|
|
Quark Pharmaceuticals inks $680 million drug licensing deal with Novartis
19 August 2010
|
|
|
Novartis penalised $250 million for gender bias against women
20 May 2010
|
|
|
Novartis acquires generic respiratory drug maker Oriel Therapeutics
19 April 2010
|
|
|
Alcon directors deride Novartis offer as grossly inadequate
20 January 2010
|
|
|
Novartis acquires 52 per cent additional stake in Alcon for $28.1 billion
04 January 2010
|
|
|
Novartis acquires Corthera, gets global rights to new heart drug
23 December 2009
|
|
|
IBM, Novartis, Vodafone in novel venture to combat malaria in Africa
15 December 2009
|
|
|
Novartis gains rights to two oral investigational therapies for life-threatening blood disorders, cancers
25 November 2009
|
|
|
Novartis enters into $265-million schizophrenia drug deal with Vanda
13 October 2009
|
|
|
Novartis acquires global marketing rights for new drug from Paratek
09 October 2009
|
|
|
Novartis moves Supreme Court on Glivec patent
29 August 2009
|
|
|
Novartis' patent aplication for cancer drug Glivec rejected
07 July 2009
|
|
|
Sandoz receives approval for first-ever Japanese biosimilar
25 June 2009
|
|
|
Novartis ups offer price for Indian arm to Rs450 per share
28 May 2009
|
|
|
Novartis's open offer for Indian arm to begin on 14 May
27 March 2009
|
|
|
Novartis makes open offer for 39 per cent in Indian arm
25 March 2009
|
|
|
J&J, GSK, Novartis eye world's top dermatologist Stiefel
21 March 2009
|
|
|
Unicef, Novartis among Mudra's new acounts
09 December 2008
|
|
|
Novartis announces strategic partnership with Lonza to boost biologics pipeline
11 July 2008
|
|
|
Novartis to buy Swiss biotech company Speedel for $880 million
11 July 2008
|
|
|
Novartis completes first step acquisition of 25-per cent stake in Alcon from Nestlé
08 July 2008
|
|
|
Novartis buys US drug firm Protez for around $400 million
04 June 2008
|
|
|
Novartis Research announces breakthrough in restoring light sensitivity in damaged retinas
29 April 2008
|
|
|
Novartis to acquire Nestle stake in eye care major Alcon for $11 billion
07 April 2008
|
|
|
New Novartis Research Institute first to focus on innovative vaccines for the developing world
23 February 2008
|
|
|
Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis
21 January 2008
|
|
|
Novartis plans to cut 22,00 jobs worldwide
13 December 2007
|
|
|
US
FDA declares Novartis painkiller Prexige is ''not approvable''
28 September 2007
|
|
|
Switzerland
not to take Novartis case before WTO
08 August 2007
|
|
|
Chennai
court rejects Novartis patent challenge
06 August 2007
|
|
|
Novartis
AG receives first worldwide approval in US for Alzheimer''s
patch
09 July 2007
|
|
|
Nestle to acquire Gerber for $5.5 billion; eyes US expansion
12 April 2007
|
|
|
Government
warns Novartis of compulsory licensing
10 April 2007
|
|
|
India
court reserves order in Novartis patent case
05 April 2007
|
|
|
Novartis
slumps after pulling Zelnorm
31 March 2007
|
|
|
Novartis patent case a threat to developing nations: Medecins Sans Frontieres
30 January 2007
|
|
|
Nestle acquires Novartis nutrition food unit for $2.5 billion
15 December 2006
|
|
|
Diovan receives
EU approval for the treatment of heart attack survivors
10 May 2005
|
|
|
Novartis
launches development centre in Mumbai
28 April 2004
|
|
|
In
the giving phase of life
25 September 2003
|
|
|
Novartis
discontinues development of Dr Reddy’s compound
24 January 2003
|
|
|
Novartis
acquires global rights for Torrent’s AGE compound
07 November 2002
|
|
|
Novartis
sale of property to Kingston through
09 September 2002
|
|
|
Glaxo
SmithKline to sue
Novartis, Ranbaxy
23 August 2002
|
|
|
Novartis
goes on with Dr Reddys work
26 December 2001
|
|
|
Zelmac withdrawn over
disagreements on clinical results
01 June 2001
|
|
|
Novartis to distribute cancer
drug free to needy
11 May 2001
|
|
|
Novartis acquires 20 per cent
stake in Roche
08 May 2001
|
|
|
Novartis'' blockbuster drug for
leukemia
27 January 2001
|
|
|
Novartis, Nicholas to buy
Hoechst units
16 October 1999
|
